Rapidly progressing primary splenic angiosarcoma with fatal hemorrhagic event.
J Chemother
; 26(4): 248-52, 2014 Aug.
Article
in En
| MEDLINE
| ID: mdl-24139479
Primary angiosarcoma of the spleen is an extremely rare malignancy. Splenic angiosarcoma is difficult to diagnose, and treatment is often challenging. The prognosis is dismal, with a mean survival of less than 1 year. Currently, no standard treatment methods have been established. Anecdotal reports suggest that early diagnosis and prompt splenectomy followed by cytotoxic chemotherapy can be effective treatment modalities. We report a case of rapidly progressing primary splenic angiosarcoma with multiple liver and bone metastases and a fatal hemorrhagic outcome.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Splenic Neoplasms
/
Bone Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Hemangiosarcoma
/
Liver Neoplasms
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
J Chemother
Journal subject:
ANTINEOPLASICOS
/
TERAPIA POR MEDICAMENTOS
Year:
2014
Document type:
Article
Country of publication:
United kingdom